In the early days, BNP was discovered as a biomarker for the identification of congestive heart failure patients, and later studies revealed that high levels of BNP in cardiac tissues indicate cardiac hypertrophy or atrial fibrillation [20,21,22,23]. Here, NPPB is linked to cardiac hypertrophy.